Moderna
MRNA
#1301
Rank
ยฃ12.58 B
Marketcap
ยฃ32.22
Share price
-5.95%
Change (1 day)
8.34%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ8.06 M-87.92%
2025ยฃ66.81 M-57.25%
2024ยฃ0.15 B15.08%
2023ยฃ0.13 B-50.15%
2022ยฃ0.27 B-85.7%
2021ยฃ1.90 B158.2%
2020ยฃ0.73 B369.18%
2019ยฃ0.15 B1011.49%
2018ยฃ14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ24.94 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ93.01 Mยฃ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ36.21 Mยฃ0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/Aยฃ5.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.09 Mยฃ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ9.93 Mยฃ38.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ3.87 Mยฃ10.57 M๐Ÿ‡บ๐Ÿ‡ธ USA